AOBCOHORT4
top of page
cooley.png

Athena on Boards | Cohort 4

September 2020 - January 2021 | POWERED BY COOLEY

HELEN BAPTIST

Chief Operating Officer

PathFactory

DIANA BODDEN

Marketing Executive | Pharmaceutical | Diagnostics | Oncology

Launch

ANITA BUSQUETS

Chief Financial Officer | Toragen Biotechnologies
President

Biotechnology Management Consultants

LATANÉ CONANT

Chief Market Officer

6sense

KAREN DAVIES

VP, Business Transformation

Quidel

ILENE J KLEIN

Founder & President

Illene J Klien, MD, FAAFP; A Professional Corporation

ALISON LOWERY

VP Finance & Accounting

Sonepar USA

BERNADETTE McBREARTY

VP Marketing, SaaS Business

ResMed

TAWN NGUYEN

Associate Director

Scripps Research

MEGAN NORVELL

Director Scientific Affairs |
Principal Consultant

Thermo Fisher Scientific | Breakaway Bio

ANNA-MARIA HAYS PUTNAM

Executive Director, Product Development

Halozyme

CYNTHIA SENER

Chief Revenue Officer

Chatmeter

CYNTHE SIMS

President

Torreyana

ERIKA SINNER

Founder

Directorie

DEBORAH SLEE

SVP, Nonclinical Development & Operations

Gossamer Bio

KELLY VAIL

VP, Business Acceleration Delivery Operations

First Republic Bank

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

Athena on Boards Committee

bottom of page